CSIMarket
 


Axim Biotechnologies Inc   (AXIM)
Other Ticker:  
 

Axim Biotechnologies Inc 's Quick Ratio

AXIM's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Regardless of the sequential decrease in Current Liabilities, during the third quarter 2023, Quick Ratio deteriorated to 0.01 below Axim Biotechnologies Inc 's average Quick Ratio.

Within Major Pharmaceutical Preparations industry 436 other companies have achieved higher Quick Ratio than Axim Biotechnologies Inc in third quarter 2023. While Quick Ratio total ranking has improved so far during the III Quarter 2023 to 3813, from total ranking in the second quarter 2023 at 4205.

Explain Quick Ratio?
How much Cash & cash equivalents AXIM´s has?
What are AXIM´s Current Liabilities?


AXIM Quick Ratio (Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Current Liabilities Change 35.25 % 208.52 % 44.69 % 29.59 % 98.33 %
Y / Y Cash & cash equivalent Change -80.9 % 51.81 % -85.83 % -88.58 % -50.13 %
Quick Ratio MRQ 0.01 0.01 0.01 0.02 0.05
AXIM's Total Ranking # 3813 # 4205 # 4269 # 5127 # 4459
Seq. Current Liabilities Change -48.86 % 72.01 % 45.4 % 5.74 % 16.66 %
Seq. Cash & cash equivalent Change -69.74 % 81.94 % 11.97 % -69.02 % 140.51 %



Quick Ratio third quarter 2023 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 437
Healthcare Sector # 892
Overall Market # 3813


Quick Ratio Statistics
High Average Low
0.84 0.23 0
(Mar 31 2019)   (Dec 31 2013)




Financial Statements
Axim Biotechnologies Inc 's Current Liabilities $ 4 Millions Visit AXIM's Balance sheet
Axim Biotechnologies Inc 's Cash & cash equivalent $ 0 Millions Visit AXIM's Balance sheet
Source of AXIM's Sales Visit AXIM's Sales by Geography


Cumulative Axim Biotechnologies Inc 's Quick Ratio

AXIM's Quick Ratio for the trailling 12 Months

AXIM Quick Ratio

(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Current Liabilities TTM Growth 35.25 % 208.52 % 44.69 % 29.59 % 98.33 %
Y / Y Cash & cash equivalent TTM Growth -80.9 % 51.81 % -85.83 % -88.58 % -50.13 %
Quick Ratio TTM 0.01 0.02 0.02 0.06 0.09
Total Ranking TTM # 3403 # 3720 # 4192 # 4474 # 3553
Seq. Current Liabilities TTM Growth -48.86 % 72.01 % 45.4 % 5.74 % 16.66 %
Seq. Cash & cash equivalent TTM Growth -69.74 % 81.94 % 11.97 % -69.02 % 140.51 %


On the trailing twelve months basis Due to drop in Current Liabilities in the III Quarter 2023 to $4.28 millions, cumulative Quick Ratio decreased to 0.01 below the Axim Biotechnologies Inc average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Major Pharmaceutical Preparations industry 456 other companies have achieved higher Quick Ratio than Axim Biotechnologies Inc . While Quick Ratio overall ranking has improved so far to 3403, from total ranking during the twelve months ending second quarter 2023 at 3720.

Explain Quick Ratio?
How much Cash & cash equivalents AXIM´s has?
What are AXIM´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry # 457
Healthcare Sector # 945
Within the Market # 3403


trailing twelve months Quick Ratio Statistics
High Average Low
0.62 0.26 0.01
(Sep 30 2019)   (Sep 30 2023)




Companies with similar Quick Ratio in the quarter ending Sep 30 2023, within Major Pharmaceutical Preparations Industry Quick RatioSep 30 2023 MRQ Cash & cash equivalentSep 30 2023 MRQ Current Liabilities
Vaccinex Inc   0.02 $ 0.127  Millions$ 6.195  Millions
Baudax Bio Inc   0.02 $ 0.363  Millions$ 19.051  Millions
Oncotelic Therapeutics Inc   0.02 $ 0.268  Millions$ 17.111  Millions
Avenir Wellness Solutions Inc   0.01 $ 0.189  Millions$ 12.789  Millions
Acer Therapeutics Inc   0.01 $ 0.595  Millions$ 61.670  Millions
Kaya Holdings Inc  0.01 $ 0.060  Millions$ 7.771  Millions
Axim Biotechnologies Inc   0.01 $ 0.032  Millions$ 4.278  Millions
Celularity Inc 0.00 $ 0.273  Millions$ 84.632  Millions
Novaccess Global Inc 0.00 $ 0.021  Millions$ 7.861  Millions
Biostax Corp 0.00 $ 0.010  Millions$ 4.212  Millions
Propanc Biopharma Inc 0.00 $ 0.007  Millions$ 3.133  Millions
China Health Industries Holdings Inc 0.00 $ 0.012  Millions$ 5.961  Millions
Aridis Pharmaceuticals Inc 0.00 $ 0.035  Millions$ 17.482  Millions
Impel Pharmaceuticals Inc 0.00 $ 0.239  Millions$ 124.743  Millions

Date modified: 2023-11-21T23:05:36+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com